{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["005a9e00-5a74-4e39-b7be-5779b2da75ba", "Q2", 8511, "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 112734, "TUBEROUS SCLEROSIS ALLIANCE", 2008, "second_quarter", "2008-07-14T12:34:11-04:00", 20000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/005a9e00-5a74-4e39-b7be-5779b2da75ba/\", \"filing_uuid\": \"005a9e00-5a74-4e39-b7be-5779b2da75ba\", \"filing_type\": \"Q2\", \"filing_type_display\": \"2nd Quarter - Report\", \"filing_year\": 2008, \"filing_period\": \"second_quarter\", \"filing_period_display\": \"2nd Quarter (Apr 1 - June 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/005a9e00-5a74-4e39-b7be-5779b2da75ba/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"20000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Joyce Briscoe, VP-Administration\", \"dt_posted\": \"2008-07-14T12:34:11-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"600 Maryland Avenue, SW\", \"registrant_address_2\": \"SUITE 835W\", \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20024\", \"registrant\": {\"id\": 8511, \"url\": \"https://lda.senate.gov/api/v1/registrants/8511/\", \"house_registrant_id\": 31321, \"name\": \"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.\", \"description\": \"Consultant firm\", \"address_1\": \"600 Maryland Avenue SW\", \"address_2\": \"Suite 220E\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20024\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"KATINA PIERCE\", \"contact_telephone\": \"+1 202-484-1100\", \"dt_updated\": \"2026-01-09T10:20:33.802241-05:00\"}, \"client\": {\"id\": 112734, \"url\": \"https://lda.senate.gov/api/v1/clients/112734/\", \"client_id\": 378, \"name\": \"TUBEROUS SCLEROSIS ALLIANCE\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"MD\", \"state_display\": \"Maryland\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-07-30\"}, \"lobbying_activities\": [{\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"S. 3230, Labor-HHS-Education Appropriations Bill, FY 2009, Tuberous Sclerosis\\nNo bill, Defense Appropriations bill, FY 2009, Tuberous Sclerosis Complex Research Program\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 32743, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MARK\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"VIETH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 1960, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DOMENIC\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RUSCIO\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 134, \"name\": \"Centers For Disease Control & Prevention (CDC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"S. 3230, Labor-HHS-Education Appropriations Bill, FY 2009, Tuberous Sclerosis\\nNo bill, Defense Appropriations Bill, FY 2009, Tuberous Sclerosis Complex research Program\\nFDA review of vigabatrin\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 32743, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MARK\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"VIETH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 1960, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DOMENIC\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RUSCIO\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 134, \"name\": \"Centers For Disease Control & Prevention (CDC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"FDA coverage of vigabatrin\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 32743, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MARK\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"VIETH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 1960, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DOMENIC\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RUSCIO\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 134, \"name\": \"Centers For Disease Control & Prevention (CDC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}", "DC", "US", 31321, "MD", null, "US", "US", null, 0, 0, 1855380, null, "alias", 0.85]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json", "registrant_state", "registrant_country", "registrant_house_id", "client_state", "client_ppb_state", "client_country", "client_ppb_country", "client_general_description", "client_government_entity", "affiliated_org_count", "client_entity_id", "client_government_unit_id", "client_match_method", "client_match_confidence"], "primary_keys": ["filing_uuid"], "primary_key_values": ["005a9e00-5a74-4e39-b7be-5779b2da75ba"], "units": {}, "query_ms": 28.586179949343204, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}